33 studies found for:    "familial male-limited precocious puberty" OR "Puberty, Precocious"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
Conditions: Precocious;   Leuprolide Acetate;   Luteinizing Hormone (LH);   Gonadotrophin-releasing Hormone Agonist (GnRHa);   Tanner Staging;   Depot Formulation;   Suppression of LH;   Central Precocious Puberty (CPP);   Gonadotrophin-releasing Hormone (GnRH);   Lupron;   GnRH Analog;   Pediatrics Central Precocious Puberty
Intervention: Drug: Leuprolide Acetate 3 Month Depot
2 Recruiting Natural History Study of Patients With Excess Androgen
Conditions: Excess Androgen;   Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:
3 Completed
Has Results
Study of Lupron Depot In The Treatment of Central Precocious Puberty
Condition: Puberty, Precocious
Intervention: Drug: Lupron (leuprolide acetate)
4 Completed
Has Results
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Condition: Puberty, Precocious
Interventions: Drug: Leuprolide acetate 11.25 mg;   Drug: Leuprolide acetate 30 mg
5 Unknown  Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Conditions: Central Precocious Puberty;   Sexual Precocity
Interventions: Drug: Triptorelin acetate and Gonadorelin acetate;   Drug: Gonadorelin acetate and Triptorelin acetate
6 Active, not recruiting
Has Results
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Condition: Puberty, Precocious
Interventions: Drug: Bicalutamide;   Drug: Anastrozole
7 Completed Treatment of Boys With Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: Spironolactone;   Drug: Testolactone;   Drug: Deslorelin
8 Completed Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Histrelin Subcutaneous Implant
9 Active, not recruiting
Has Results
Faslodex in McCune Albright Syndrome
Conditions: Puberty, Precocious;   McCune-Albright Syndrome
Intervention: Drug: Fulvestrant
10 Not yet recruiting Follow-up of Girls With Premature Thelarche and Precocious Puberty
Conditions: Precocious Puberty;   Excess; Development, Breast
Intervention:
11 Recruiting Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
Condition: Early Puberty
Intervention:
12 Not yet recruiting Markers of Pubertal Suppression During Therapy for Precocious Puberty
Condition: Central Precocious Puberty
Intervention:
13 Completed Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Letrozole
14 Recruiting First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty
Condition: Precocious Puberty, Gonadotropin-dependent
Interventions: Other: Measurement of LH in first-voided urine;   Other: collection of first-voided urine sample for LH level
15 Unknown  Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Condition: Central Precocious Puberty
Interventions: Drug: Triptorelin (GnRH agonists);   Drug: Leuprolide (GnRH agonists)
16 Completed
Has Results
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Condition: Precocious Puberty
Intervention: Drug: Triptorelin pamoate 11.25mg (Decapeptyl® SR)
17 Completed Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Conditions: Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Testolactone
18 Active, not recruiting Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Condition: Precocious Puberty
Intervention: Drug: Triptorelin (I.N.N.)
19 Active, not recruiting Efficacy, Safety, and PK of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Triptorelin 22.5 mg
20 Unknown  The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Luphere depot 3.75mg(Leuprolide acetate 3.75mg)

Previous Page Studies Shown (1-20) Next Page (21-33) Show next page of results
Indicates status has not been verified in more than two years